Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7380 p733-738
17 December 2005

This section
Reprint   Photocopy

PDF 170K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

733 Pharmacists should ask LPCs about smartcards Community pharmacists should find out when their primary care trust will issue them with the smartcard essential for them to take part in the electronic prescription service (EPS) before they commit themselves to paying for the costs of the computer connection, pharmacy negotiators warned this week ...more

733 Pharmacist projects win national awards Two medicines management projects involving pharmacists were among the winners of the inaugural general medical services and personal medical services Awards of Excellence, presented at the NHS Alliance Conference in Harrogate, North Yorkshire, this week ...more

733 Review limit raised to 250 The maximum number of medicines use reviews that can be carried out during the first year of the new community pharmacy contract has been increased from 200 to 250, the Department of Health has confirmed ...more

733 Leaflet for patients on drug side effects developed by MHRA A patient leaflet that contains questions and answers on the side effects of medicines has been produced by the Medicines and Healthcare products Regulatory Agency ...more

734 Social-value judgements not relevant to health care Treatment should not be denied to patients with conditions that may be self-inflicted, the National Institute for Health and Clinical Excellence says in a report published last week ...more

734 Implementing NICE guidance Practical advice on implementing National Institute for Health and Clinical Excellence guidance was published by NICE in the form of a “How to” guide last week ...more

734 Lack of NICE guidance cannot be sole reason for withholding treatment from NHS patients It is not acceptable for NHS organisations to cite a lack of National Institute for Health and Clinical Excellence guidance as the sole reason for not providing a treatment, according to health minister Jane Kennedy ...more

734 SMC issues guidance on six more drugs The Scottish Medicines Consortium this week accepted five drugs for use within NHS Scotland and rejected one ...more

734 NHS complaints Complaints about the NHS in Scotland fell by 3.2 per cent in the financial year 2004–05 compared with the previous year ...more

734 Scotland's obesity problem Obesity among children in Scotland has increased over the past five years, statistics released by NHS Scotland this week show ...more

735 Society criticised despite winning High Court appeal Manchester pharmacist Allan Stuart Black was rightly struck off by the Royal Pharmaceutical Society's Statutory Committee earlier this year, a High Court judge has ruled. However, the judge criticised the Society for treating him unfairly despite dismissing Mr Black's appeal ...more

735 Prevention in NHS reforms Health Secretary Patricia Hewitt has pledged that the next raft of reforms in the NHS will move away from acute care to prevention, and health and social care in the community ...more

735 NHS efficiency savings ahead of schedule Efficiency savings in the NHS in England are ahead of schedule, the Secretary of State for Heath, Patricia Hewitt, has said ...more

735 Union issues lobbying call over health service reform Amicus is urging its members to lobby their members of Parliament over Government proposals to reform health services ...more

735 Hospital pharmacists migrate to primary care Pharmacists who work exclusively in primary care are more likely to have come from the hospital than the community sector, a paper in this month's International Journal of Pharmacy Practice reveals ...more

736 Switch to aromatase inhibitor improves survival Replacing tamoxifen with anastrozole (Arimidex) improves survival of patients with early breast cancer compared with continuing on tamoxifen for five years, according to results from the first study to show a survival benefit of changing hormonal therapy ...more

736 COX-2 inhibitor launched by Novartis A new selective cyclo-oxygenase-2 (COX-2) inhibitor has been launched by Novartis ...more

736 Adding trastuzumab increases survival Treatment with trastuzumab (Herceptin) at the same time as, or following, chemotherapy increased disease-free survival in a trial of 3,222 women with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer ...more

737 Pharmacists consulted on paediatric formulations Pharmacists are being consulted on their views about the formulation of children's medicines, which might bring about new European guidelines for the pharmaceutical industry ...more

737 More licensed child medicines a step closer Having more medicines licensed for use in children came a step closer last week with approval of a research incentive scheme by the EU Council of Ministers ...more

737 Toxic herbal medicines alert Consumers are warned by the Medicines and Healthcare products Regulatory Agency not to purchase or use two African herbal remedies — M2 and Energy 2000 ...more

737 ACE inhibitors and ARBs not always best in kidney disease Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers are not necessarily better than other antihypertensives in preventing kidney disease, a review of evidence suggests ...more

737 Study questions routine prophylaxis against thromboembolism after fracture below the knee Fractures below the knee do not warrant routine prophylaxis against venous thromboembolism, concludes a Canadian prospective cohort study presented at the 47th annual meeting of the American Society of Hematology in Atlanta, Georgia, this week ...more

737 100th Nucare PLUS store Nucare has opened its 100th Nucare PLUS store — part of the upgrade scheme for Nucare pharmacies — in Tyldesley, Manchester ...more

738 Pharmacy IT must evolve for future contract needs Key to finding the most appropriate IT system to support the new community pharmacy contract is identifying one that will evolve over time to meet both current and future needs, according to Nick Strong, managing director of Systems Solutions ...more

738 Pharmacist wins “Leader for change” award Joel Hirst, a pharmacist and quality improvement facilitator in medicines and pharmacy at Bristol North Primary Care Trust, has won a “Leaders for change” award for a project that focuses on increasing the role of community pharmacists in the provision of local health services ...more

738 System implemented to aid rational clinically led drug selection in Northern Ireland Pharmacists in Northern Ireland and the Netherlands have collaborated to develop and implement an evidence-based, transparent process for drug selection ...more

Back to Top


©The Pharmaceutical Journal